BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1954687)

  • 1. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia: reperfusion injury and restenosis after coronary angioplasty.
    Park JW; Braun P; Mertens S; Heinrich KW
    Ann N Y Acad Sci; 1992 Sep; 669():215-36. PubMed ID: 1444028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
    Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fabbri M; Fontanelli A; Monici Preti PA; Repetto S; De Servi S
    Circulation; 1994 Dec; 90(6):2710-5. PubMed ID: 7994812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis after coronary angioplasty.
    Anderson HV; Vignale SJ; Benedict CR; Willerson JT
    J Interv Cardiol; 1993 Sep; 6(3):187-202. PubMed ID: 10151016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Restenosis after coronary angioplasty: status in 1994].
    Vojácek J
    Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty.
    Monsen CH; Adams PC; Badimon L; Chesebro JH; Fuster V
    Z Kardiol; 1987; 76 Suppl 6():23-8. PubMed ID: 2964144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis following coronary angioplasty.
    Fanelli C; Aronoff R
    Am Heart J; 1990 Feb; 119(2 Pt 1):357-68. PubMed ID: 2405612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Okamoto S; Inden M; Setsuda M; Konishi T; Nakano T
    Am Heart J; 1992 Jun; 123(6):1439-44. PubMed ID: 1595521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.
    Lefkovits J; Topol EJ
    Prog Cardiovasc Dis; 1997; 40(2):141-58. PubMed ID: 9327830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of restenosis after coronary angioplasty].
    Leclercq F; Grolleau R
    Arch Mal Coeur Vaiss; 1996 Mar; 89(3):359-65. PubMed ID: 8734189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience.
    Roubin GS; King SB; Douglas JS
    Am J Cardiol; 1987 Jul; 60(3):39B-43B. PubMed ID: 2956840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis after coronary angioplasty.
    Anderson HV
    Dis Mon; 1993 Sep; 39(9):613-70. PubMed ID: 8359109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.
    Liu MW; Roubin GS; King SB
    Circulation; 1989 Jun; 79(6):1374-87. PubMed ID: 2524293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.